Morphosys grows surprisingly strongly at the start of the year

After an unexpectedly strong final quarter of 2022, biotech company Morphosys has also performed surprisingly well at the start of the year. The Bavarian company's sales jumped in the first quarter.... | May 4, 2023

Related Keywords

United States ,Jean Paul Kress ,James Gordon ,Rajan Sharma ,Constellation Pharmaceuticals ,Goldman Sachs ,Management Board ,Morphosys Ag Stock Exchange ,News ,Information ,Press Release ,After ,N ,Nexpectedly ,Strong ,Final ,Quarter ,F ,Biotech ,Company ,Morphosys ,Gas ,Also ,Erformed ,Unsurprisingly ,Fell ,It ,The ,Start ,Bavarian ,Sales ,Umped ,Irst Mor De0006632003 ,